Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 4 |
Descriptor
| Behavior Modification | 4 |
| Drug Therapy | 4 |
| Behavior Problems | 2 |
| Case Studies | 2 |
| Child Behavior | 2 |
| Comparative Analysis | 2 |
| Outcomes of Treatment | 2 |
| Symptoms (Individual… | 2 |
| Adolescents | 1 |
| Aggression | 1 |
| Antisocial Behavior | 1 |
| More ▼ | |
Source
| Journal of Attention Disorders | 1 |
| Journal of Autism and… | 1 |
| Journal of Clinical Child and… | 1 |
| Journal of the American… | 1 |
Author
| Findling, Robert L. | 4 |
| Kratochvil, Christopher J. | 2 |
| Brams, Matthew | 1 |
| Breddy, John | 1 |
| Childress, Ann C. | 1 |
| Curry, John F. | 1 |
| Feeny, Norah C. | 1 |
| Ginsburg, Golda S. | 1 |
| Gringras, Paul | 1 |
| Jensen, Peter S. | 1 |
| Kennard, Betsy D. | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 4 |
| Reports - Research | 2 |
| Opinion Papers | 1 |
| Reports - Evaluative | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Strengths and Difficulties… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkSchroder, Carmen M.; Malow, Beth A.; Maras, Athanasios; Melmed, Raun D.; Findling, Robert L.; Breddy, John; Nir, Tali; Shahmoon, Shiri; Zisapel, Nava; Gringras, Paul – Journal of Autism and Developmental Disorders, 2019
A randomized, 13-weeks, placebo-controlled double-blind study in 125 subjects aged 2-17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia demonstrated efficacy and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2-5 mg) in improving sleep duration and onset. Treatment effects on child…
Descriptors: Autism, Pervasive Developmental Disorders, Genetic Disorders, Sleep
Findling, Robert L.; Brams, Matthew; Childress, Ann C.; Lopez, Frank A.; Manos, Michael J.; Jensen, Peter S. – Journal of Attention Disorders, 2011
ADHD is one of the most common neurobehavioral disorders of childhood, and FDA-approved medications offer an efficacious treatment option. However, case reports and anecdotal sources suggest that children can have emotional responses, both salutary and detrimental, to these agents. We have previously conducted a comprehensive literature review and…
Descriptors: Attention Deficit Hyperactivity Disorder, Research Methodology, Drug Therapy, Emotional Response
Feeny, Norah C.; Silva, Susan G.; Reinecke, Mark A.; McNulty, Steven; Findling, Robert L.; Rohde, Paul; Curry, John F.; Ginsburg, Golda S.; Kratochvil, Christopher J.; Pathak, Sanjeev M.; May, Diane E.; Kennard, Betsy D.; Simons, Anne D.; Wells, Karen C.; Robins, Michele; Rosenberg, David; March, John S. – Journal of Clinical Child and Adolescent Psychology, 2009
This article explores aspects of family environment and parent-child conflict that may predict or moderate response to acute treatments among depressed adolescents (N = 439) randomly assigned to fluoxetine, cognitive behavioral therapy, their combination, or placebo. Outcomes were Week 12 scores on measures of depression and global impairment. Of…
Descriptors: Conflict, Cognitive Restructuring, Adolescents, Family Environment
Findling, Robert L.; Newcorn, Jeffrey H.; Malone, Richard P.; Waheed, Ayesha; Prince, Jefferson B.; Kratochvil, Christopher J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
A 9-year-old boy presents for assessment and treatment of his reactive, impulsive aggressive behavior that has been present for approximately 2 years. Six months ago, his pediatrician started treatment with OROS methylphenidate (MPH), which was titrated to 36 mg/day. There was moderate improvement in symptoms of attention-deficit/hyperactivity…
Descriptors: Hyperactivity, Aggression, Attention Deficit Disorders, Drug Therapy
